In winning the competition, Player 831 hopes to fund critical research, drug development, clinical trials, and resources for ...
which includes the Celiac Disease and Connective Tissue Diseases (CTD) Essential Reagents. This latest clearance expands the Aptiva portfolio to 18 FDA-cleared analytes. Looking ahead, Werfen is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results